Pfeiffer Syndrome Type 1

Watchlist
Retrieved
2021-01-23
Source
Trials
Drugs

Pfeiffer syndrome type 1 (PS1) is a mild to moderately severe type of Pfeiffer syndrome (PS; see this term), characterized by bicoronal craniosynostosis, variable finger and toe malformations, and in most cases, normal intellectual development.

Epidemiology

The exact annual incidence of this form of PS is not known but the incidence of all forms of PS is 1/100,000.

Clinical description

PS1 concerns patients with an overall mildly to moderately severe clinical picture and a generally favorable course. Patients present with bicoronal craniosynostosis, moderate to severe mid-face hypoplasia, broad medially deviated thumbs and halluces, and variable brachydactyly and syndactyly. Associated features may include bilateral symmetrical hearing loss and hydrocephalus. Milder phenotypes typically allow for normal brain development, limiting the number of associated complications. Intelligence is usually normal or just below average. In mild cases, the need for corrective surgery is also limited. Congenital airway compromise is not a complication in type 1 patients. PS1 has a much more favorable prognosis than PS type 2 or type 3.

Etiology

PS1 is most commonly caused by mutations in the FGFR2 gene (10q25.3-q26), and in rare instances by mutations in the FGFR1 gene (8p11.23-p11.22).

Genetic counseling

Pfeiffer syndrome follows an autosomal dominant pattern of inheritance, observed primarily in non-severe cases compatible with long-term survival. Genetic counseling for affected families is recommended.

Prognosis

Due to decreased need for extensive corrective surgery and essentially normal intellectual development, overall prognosis in PS1 is much more favorable than in Pfeiffer syndrome type 2 or type 3.